NauseaAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantPostoperative Nausea and VomitingVomitingAntiemeticsAntineoplastic AgentsCisplatinCombined Modality TherapyTreatment OutcomeDoxorubicinCyclophosphamideOndansetronDrug Administration ScheduleNeoadjuvant TherapyDisease-Free SurvivalBreast NeoplasmsEtoposideNeoplasm StagingSurvival AnalysisLung NeoplasmsSurvival RatePrognosisNeoplasmsCarboplatinMethotrexatePaclitaxelVinblastineGranisetronTaxoidsVomiting, AnticipatoryNeoplasm Recurrence, LocalDeoxycytidineInduction ChemotherapyAntimetabolites, AntineoplasticIfosfamideDrug Resistance, NeoplasmProchlorperazineBleomycinMotion SicknessInfusions, IntravenousMetoclopramideOrganoplatinum CompoundsAnthracyclinesFollow-Up StudiesNeutropeniaSalvage TherapyAntineoplastic Agents, AlkylatingCarcinoma, Non-Small-Cell LungNeoplasm MetastasisAcupressureProspective StudiesCytarabineSerotonin 5-HT3 Receptor AntagonistsOvarian NeoplasmsTime FactorsDose-Response Relationship, DrugAntineoplastic Agents, PhytogenicChemotherapy, Cancer, Regional PerfusionMorning SicknessAdenocarcinomaDroperidolCamptothecinLeukopeniaTesticular NeoplasmsLymphoma, Non-HodgkinTransplantation, AutologousRadiotherapyClinical Trials as TopicRadiotherapy, AdjuvantColorectal NeoplasmsHodgkin DiseaseDouble-Blind MethodAntibiotics, AntineoplasticDacarbazineDrug EvaluationGranulocyte Colony-Stimulating FactorKaplan-Meier EstimateNeoplasms, Germ Cell and EmbryonalBrain NeoplasmsBone NeoplasmsHyperemesis GravidarumPalliative CarePlatinum CompoundsInfusions, Intra-ArterialDexamethasoneRandomized Controlled Trials as TopicCarmustineTegafurLomustinePeritoneal NeoplasmsLiver NeoplasmsMitomycinStomach NeoplasmsAdministration, OralRecurrenceMitoxantroneMelphalanThiotepaThrombocytopenia